Syros Pharmaceuticals, Inc.
USD0.00
+0.00 (+0.00%)
CEO
James E. Bradner
IPO Date
2016-06-30
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.04
Market Cap
$0.00B
Volume
0.00M
| 134,713 |
| $0.27 |
| 20 Nov 2024 | Roth David | Chief Medical Officer | S-Sale | Disposed | 12,099 | $0.20 |
| 20 Nov 2024 | Quirk Gerald E | Chief Legal & Compliance Offic | S-Sale | Disposed | 46,657 | $0.22 |
| 4 Nov 2024 | Roth David | Chief Medical Officer | M-Exempt | Acquired | 18,875 | $0.00 |
| 4 Nov 2024 | Roth David | Chief Medical Officer | F-InKind | Disposed | 6,776 | $2.09 |
| 4 Nov 2024 | Roth David | Chief Medical Officer | M-Exempt | Disposed | 18,875 | $0.00 |
| 4 Nov 2024 | Simonian Nancy A | director | M-Exempt | Acquired | 40,125 | $0.00 |
| 4 Nov 2024 | Simonian Nancy A | director | M-Exempt | Disposed | 40,125 | $0.00 |
| 2 Oct 2024 | Quirk Gerald E | Chief Legal & Compliance Offic | M-Exempt | Acquired | 10,000 | $0.00 |